GUGGENHIME ANDREW

Filings at 1 company/PRESIDENT AND CFO · Vaxcyte, Inc.

5 of 11 shown

The 5 most recent of 11 visible filings, newest first.

  • Vaxcyte, Inc. PRESIDENT AND CFO
    $431,876Administrative
    TradedSep 8, 2026FiledSep 9, 2026
  • Vaxcyte, Inc. PRESIDENT AND CFO
    $88,183Administrative
    TradedSep 2, 2026FiledSep 2, 2026
  • Vaxcyte, Inc. PRESIDENT AND CFO
    $77,322Administrative
    TradedAug 31, 2026FiledSep 2, 2026
  • Vaxcyte, Inc. PRESIDENT AND CFO
    10,000 sharesOption exercise
    TradedAug 3, 2026FiledAug 5, 2026
  • Vaxcyte, Inc. PRESIDENT AND CFO
    $164,918Open-market sale
    TradedAug 3, 2026FiledAug 5, 2026